Advertisement
Advertisement
U.S. markets close in 3 hours 51 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Newegg Commerce, Inc. (NEGG)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.4400+0.3500 (+8.56%)
As of 12:09PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close4.0900
Open4.0800
Bid4.3600 x 1100
Ask4.3800 x 1000
Day's Range3.9000 - 4.5500
52 Week Range3.1500 - 22.2000
Volume2,076,277
Avg. Volume598,403
Market Cap1.631B
Beta (5Y Monthly)N/A
PE Ratio (TTM)55.50
EPS (TTM)0.0800
Earnings DateApr 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-25% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for NEGG

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Newegg Commerce, Inc.
    Analyst Report: ResMed Inc.ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
    Rating
    Fair Value
    Economic Moat
    4 days agoMorningstar
View more
Advertisement
Advertisement